GO
Loading...

Rush to tax inversions

Thursday, 24 Jul 2014 | 5:46 PM ET

Discussing whether there is a rush for companies to make tax inversions, with Dr. Ron Cohen, Acorda Therapeutics founder & CEO; CNBC contributor Bethany McLean; Ron Kruszewski, Stifel Financial Chairman, President & CEO; and Arthur Brooks, American Enterprise Institute.